Does topical application of PPARα ( but not β/δ or γ ) suppress atopic dermatitis in NC/Nga mice?
Topical application of PPARα activator could be a potent therapeutic agent for patients with AD and could take the place of topical steroid treatments.
Low HRQoL correlated significantly with MELD-based organ allocation, more than 28-day hospitalization, divorced status, lower education- and non-working status, higher distance to transplant center, follow up at transplant center, HU-status, shorter waiting time to LTx and younger age. Improvement of HRQoL after LTx may require clinical management of pain, psychotherapy and financial support.